Prescrire Int. 2007 Jun;16(89):115-9.
(1) Globally, papillomavirus infections are very widespread in the general population worldwide. More than 100 genotypes of human papillomavirus (HPV) have been identified; they differ in targeted tissue and carcinogenic activity. (2) This article describes the clinical manifestations, prevalence and modes of transmission of human papillomavirus infections, and the role of HPV in human cancer. A systematic literature review was carried out to answer these questions based on methods developed by Prescrire. (3) The most frequent clinical manifestations of human papillomavirus infection are cutaneous and anogenital growths such as warts, papillomata and condylomata. The HPV genotypes linked to skin infections differ from those infecting the anogenital area. Genotypes HPV-16 and HPV-18 are frequently associated with high-grade cervical dysplasia. (4) The frequency of HPV infections varies widely from one population to another. HPV (usually genotype 16) is found in 1.5% to 44% of cervical smears. In the 1990s, 25% of women between 20 and 29 years of age in the United States were seropositive for HPV-16. (5) Papillomavirus is highly persistent in the environment, on contaminated objects, linen, floors. Skin infections can occur through indirect or direct contact. Most anogenital infections are sexually transmitted. (6) Most papillomavirus infections are asymptomatic, latent or transient. Various factors, especially immunosuppression, increase the persistence and severity of infections, and can promote progression to cancer. (7) The DNA of some highly carcinogenic HPV genotypes (especially HPV-16 and HPV-18) is present in 95% to 100% of cervical epidermoid tumours. Malignant transformation of lesions due to HPV seems to be facilitated by HPV persistence, a high HPV viral load in the cervix, and immunosuppression. (8) However, HPV infection rarely leads to progression to cancer. Only a minority of infections persist for several years, and only about 10% of low-grade lesions progress to a higher grade. About 5% of high-grade lesions progress to invasive cancer. (9) Other anogenital cancers, such as cancer of the anus, vulva, vagina and penis, appear to be linked to HPV (usually genotype 16). (10) Skin cancer due to HPV is rare. Some cancers of the respiratory and gastrointestinal tracts appear to be linked to HPV infection.
(1)在全球范围内,乳头瘤病毒感染在全世界普通人群中非常普遍。已鉴定出100多种人乳头瘤病毒(HPV)基因型;它们在靶向组织和致癌活性方面存在差异。(2)本文描述了人乳头瘤病毒感染的临床表现、患病率和传播方式,以及HPV在人类癌症中的作用。根据Prescrire制定的方法进行了系统的文献综述以回答这些问题。(3)人乳头瘤病毒感染最常见的临床表现是皮肤和肛门生殖器部位的赘生物,如疣、乳头瘤和湿疣。与皮肤感染相关的HPV基因型与感染肛门生殖器区域的基因型不同。HPV-16和HPV-18基因型常与高级别宫颈发育异常相关。(4)HPV感染的频率在不同人群中差异很大。在1.5%至44%的宫颈涂片样本中可检测到HPV(通常为16型)。在20世纪90年代,美国20至29岁的女性中有25%HPV-16血清学呈阳性。(5)乳头瘤病毒在环境中、受污染的物体、亚麻制品和地板上具有高度持久性。皮肤感染可通过间接或直接接触发生。大多数肛门生殖器感染是通过性传播的。(6)大多数乳头瘤病毒感染是无症状的、潜伏的或短暂的。各种因素,尤其是免疫抑制,会增加感染的持久性和严重程度,并可促进癌症进展。(7)在95%至100%的宫颈表皮样肿瘤中存在某些高致癌性HPV基因型(尤其是HPV-16和HPV-18)的DNA。HPV持续存在、宫颈中高HPV病毒载量以及免疫抑制似乎有助于HPV引起的病变发生恶性转化。(8)然而,HPV感染很少导致癌症进展。只有少数感染会持续数年,只有约10%的低级别病变会进展为更高级别。约5%的高级别病变会进展为浸润性癌症。(9)其他肛门生殖器癌症,如肛门癌、外阴癌、阴道癌和阴茎癌,似乎与HPV(通常为16型)有关。(10)由HPV引起的皮肤癌很少见。一些呼吸道和胃肠道癌症似乎与HPV感染有关。